关键词：传染病；病原微生物；直接接触；间接接触
摘 要：Infectious diseases are caused by various pathogenic microorganisms such as bacteria, fungi,parasites, or viruses.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Application

08. Global Antibacterial Drugs Market

08.1 Introduction

08.2 Market Size and Forecast

08.3 Market Segmentation by Chemical Class

08.4 Market Segmentation by Drug Origin

09. Global Antifungal Drugs Market

09.1 Introduction

09.2 Market Size and Forecast

09.3 Market Segmentation by Chemical Class

09.4 Market Segmentation by Geography

09.4.1 Antifungal Drugs Market in the US

09.4.2 Antifungal Drugs Market in Europe

10. Global Antiviral Drugs Market

10.1 Introduction

10.2 Market Size and Forecast

10.3 Market Segmentation by Disease

10.4 Global Hepatitis C Drugs Market

10.4.1 Market Size and Forecast

10.4.2 Geographical Segmentation

10.5 Global Hepatitis B Drugs Market

10.5.1 Market Size and Forecast

10.6 Global HIV Drugs Market

10.6.1 Market Size and Forecast

11. Global Antiparasitic Drugs Market

11.1 Market Size and Forecast

12. Geographical Segmentation

13. Buying Criteria

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape

20.1 Competitive Scenario

20.1.1 Key News

20.1.2 Mergers and Acquisitions

20.2 Market Share Analysis 2013

20.2.1 Gilead Sciences

20.2.2 GlaxoSmithKline

20.2.3 Pfizer

20.2.4 F. Hoffmann-La Roche

20.2.5 Johnson & Johnson

20.2.6 Merck

20.3 Other Prominent Vendors

21. Key Vendor Analysis

21.1 F. Hoffmann-La Roche

21.1.1 Key Facts

21.1.2 Business Overview

21.1.3 Business Segmentation

21.1.4 Business Segmentation by Revenue 2012 and 2013

21.1.5 Geographical Segmentation by Revenue

21.1.6 Business Strategy

21.1.7 Key Information

21.1.8 SWOT Analysis

21.2 Gilead Sciences

21.2.1 Key Facts

21.2.2 Business Overview

21.2.3 Geographical Segmentation by Revenue 2013

21.2.4 Recent Developments

21.2.5 SWOT Analysis

21.3 GlaxoSmithKline

21.3.1 Key Facts

21.3.2 Business Overview.

21.3.3 Business Segmentation

21.3.4 Business Segmentation by Revenue 2012 and 2013

21.3.5 Sales by Geography

21.3.6 Pipeline Products

21.3.7 Business Strategy

21.3.8 Key Information

21.3.9 SWOT Analysis

21.4 Johnson & Johnson

21.4.1 Key Facts

21.4.2 Business Overview

21.4.3 Business Segmentation by Revenue 20131

21.4.4 Business Segmentation by Revenue 2012 and 2013

21.4.5 Geographical Segmentation by Revenue 2013

21.4.6 Business Strategy

21.4.7 Recent Developments

21.4.8 SWOT Analysis

21.5 Merck

21.5.1 Key Facts

21.5.2 Business Overview

21.5.3 Business Segmentation by Revenue 2013

21.5.4 Business Segmentation by Revenue 2012 and 2013

21.5.5 Geographical Segmentation by Revenue

21.5.6 Business Strategy

21.5.7 Key Developments

21.5.8 SWOT Analysis

21.6 Pfizer

21.6.1 Key Facts

21.6.2 Business Overview

21.6.3 Business Segmentation

21.6.4 Business Segmentation by Revenue 2013

21.6.5 Business Segmentation by Revenue 2012 and 2013

21.6.6 Geographical Segmentation by Revenue

21.6.7 Business Strategy

21.6.8 Key Developments

21.6.9 SWOT Analysis

22. Other Reports in this Series